Immunotherapy Combination Doesn’t Affect Disease-Free Survival in dMMR Colon Cancer
Recent clinical findings presented at the European Society for Medical Oncology (ESMO) indicate that the duration of immunotherapy treatment for patients with DNA mismatch repair-deficient (dMMR) colon cancer does not ... Read More